ReviewLife metabolism2025
The pathogenic theory of homeostasis threshold deviation (HTD) in wide-range oscillatory physiological parameters: novel perspectives for hypertension and metabolic disease treatment.
Review in Life metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on current research in neuroscience, systems biology, and clinical medicine, we propose a novel theoretical concept: the "Homeostasis Threshold Deviation (HTD) Theory of Wide-Range Oscillatory Physiological Parameters". HTD posits that, when the external environment undergoes significant and sustained changes or when visceral signals exhibit long-term abnormalities, central nervous system (CNS) network topologies reset first, establishing a new range of physiological setpoints before peripheral organs adapt. This central reset leads to a deviation in the topological information network structure of central nuclei, resulting in the displacement of the original range of physiological parameters that become challenging to restore. This deviation further triggers passive adaption in peripheral organs, ultimately causing complex multi-organ diseases and severe organ dysfunction. By targeting the CNS threshold shift, HTD provides a novel path for precision medicine. That is, restoring original homeostatic setpoints could enable both early prevention and durable treatment of hypertension and metabolic disorders, achieving a "two birds with one stone" effect or even partially curing related conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.